58578-45-3

Basic information

• Product Name: 4-oxo-2S-[[(phenymethyoxy)carbonyl]amino]-butyric acid phenymethyl ester
• Synonyms: 4-oxo-2S-[[(phenymethyoxy)carbonyl]amino]-butyric acid phenymethyl ester;(S)-4-Oxo-2-[[(phenylmethoxy)carbonyl]amino]butanoic acid phenylmethyl ester;Benzyl 4-oxo-2-(S)-[[(phenylmethoxy)carbonyl]amino]butanoate;S)-benzyl 2-(benzyloxycarbonylaMino)-4-oxobutanoate;PhenylMethyl 4-oxo-2(S)-[[(plenylMethoxy)carbonyl]aMino]butanoate
• CAS NO: 58578-45-3
• Molecular Formula: C₁₉H₁₉NO₅
• Molecular Weight: 341.36
• Mol File: 58578-45-3.mol
• Article Data: 8

Chemical Properties

• Melting Point: 80.5-82 ºC
• Boiling Point: 534.1°C at 760 mmHg
• Flash Point: 276.8°C
• Appearance: /
• Density: 1.223
• Vapor Pressure: 1.74E-11mmHg at 25°C
• Refractive Index: 1.564
• PKA: 10.47±0.46(Predicted)
• CAS DataBase Reference: 4-oxo-2S-[[(phenymethyoxy)carbonyl]amino]-butyric acid phenymethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 4-oxo-2S-[[(phenymethyoxy)carbonyl]amino]-butyric acid phenymethyl ester(58578-45-3)
• EPA Substance Registry System: 4-oxo-2S-[[(phenymethyoxy)carbonyl]amino]-butyric acid phenymethyl ester(58578-45-3)

Safety Data

• Hazardous Substances Data: 58578-45-3(Hazardous Substances Data)

Usage

General Description

4-oxo-2S-[[(phenylmethoxy)carbonyl]amino]-butyric acid phenylmethyl ester is a chemical compound with potential biological properties. It is a derivative of butyric acid and contains a phenylmethyl ester group. 4-oxo-2S-[[(phenymethyoxy)carbonyl]amino]-butyric acid phenymethyl ester has been studied for its potential as an anti-cancer agent, as butyric acid derivatives have been found to exhibit anti-tumor effects. Additionally, the phenylmethyl ester group may contribute to its ability to penetrate cell membranes and target specific tissues. Further research is needed to fully understand the pharmacological properties and potential therapeutic uses of this compound.

InChI:InChI=1/C19H19NO5/c21-12-11-17(18(22)24-13-15-7-3-1-4-8-15)20-19(23)25-14-16-9-5-2-6-10-16/h1-10,12,17H,11,13-14H2,(H,20,23)

Upstream product

• 58578-44-2 benzyl L-2-<(carbobenzxyloxy)amino>-4-hydroxybutyrate 
• 100-39-0 benzyl bromide 
• 501-53-1 benzyl chloroformate 
• 35677-88-4 N-benzyloxycarbonyl-(L)-homoserine 
• 4779-31-1 Z-Asp-OBn 
• 58578-43-1 (S)-2-benzyloxycarbonylamino-4-hydroxybutyric acid dicyclohexylamine salt 
• 35677-89-5 benzyl (3S)-2-oxotetrahydro-3-furanylcarbamate 

Downstream Products

• 58578-46-4 (S)-2-Benzyloxycarbonylamino-4,4-dimethoxy-butyric acid benzyl ester 
• 109429-17-6 (2S,5R,7S)-1-aza-7-benzyloxycarbonylamino-8-oxo-4-thiabicyclo<3.3.0>octane-2-carboxylic acid methyl ester 
• 125075-17-4 (2R,5S,7R)-1-aza-7-benzyloxycarbonylamino-8-oxo-4-thiabicyclo<3.3.0>octane-2-carboxylic acid methyl ester 
• 109317-07-9 (2R,5S,7S)-1-aza-7-benzyloxycarbonylamino-8-oxo-4-thiabicyclo<3.3.0>octane-2-carboxylic acid methyl ester 
• 109317-05-7 (2ξ,4R,2'S)-<2'-(benzyloxycarbonylaminopropanoic acid benzyl ester)>-3-aza-4-(methoxycarbonyl)tetrahydrothiophene 
• 109317-05-7 (2Ξ,4S,2'S)-<2'-(benzyloxycarbonylaminopropanoic acid benzyl ester)>-3-aza-4-(methoxycarbonyl)tetrahydrothiophene 
• 125075-16-3 (2S,5R,7R)-1-aza-7-benzyloxycarbonylamino-8-oxo-4-thiabicyclo<3.3.0>octane-2-carboxylic acid methyl ester 
• 270570-20-2 (S)-2-Benzyloxycarbonylamino-4-(diisopropoxy-phosphoryl)-4-hydroxy-butyric acid benzyl ester 
• 270570-21-3 2-benzyloxycarbonylamino-4-(di-tert-butoxy-phosphoryl)-4-hydroxy-butyric acid benzyl ester 
• 270570-22-4 (S)-2-Benzyloxycarbonylamino-4-(diisopropoxy-phosphoryl)-4-(tetrahydro-pyran-2-yloxy)-butyric acid benzyl ester 
• 111772-93-1 ((S)-1-Hydroxy-2-oxo-pyrrolidin-3-yl)-carbamic acid benzyl ester 
• 111772-95-3 (S)-4-Benzyloxyamino-2-benzyloxycarbonylamino-butyric acid benzyl ester 
• 109429-19-8 (2R,3R,5S,7S)-1-aza-3-benzyloxy-7-benzyloxycarbonylamino-8-oxo-4-thiabicyclo<3.3.0>octane-2-carboxylic acid methyl ester 
• 124994-63-4 (2S,5R,7S)-1-aza-7-benzyloxycarbonylamino-8-oxo-4-thiabicyclo<3.3.0>octane-2-carboxylic acid 

Relevant articles and documents

Development of a Highly Selective Plasmodium falciparum Proteasome Inhibitor with Anti-malaria Activity in Humanized Mice

Plasmodium falciparum proteasome (Pf20S) inhibitors are active against Plasmodium at multiple stages—erythrocytic, gametocyte, liver, and gamete activation stages—indicating that selective Pf20S inhibitors possess the potential to be therapeutic, prophyla

MACROCYCLIC COMPOUNDS AS PROTEASOME INHIBITORS

The compounds of the present invention are represented by the following compounds having Formula I and Formula (I'): where the substituents R1, R2, R2', R3, R4, R5, R', R", X, Y, and Z are as defined herein and where the substituents R1, R2, R3, R4, R5, R', R", X, Y, and Z are as defined herein. These compounds are used in the treatment of bacterial infections, parasite infections, fungal infections, cancer, immunologic disorders, autoimmune disorders, neurodegenerative diseases and disorders, inflammatory disorders, or muscular dystrophy or for providing immunosuppression for transplanted organs or tissues.

Concise Synthesis of Enantiomerically Pure (1′S,2′R)-and (1′R,2′S)-2S-Amino-3-(2′-aminomethyl-cyclopropyl)propionic Acid: Two E-Diastereoisomers of 4,5-Methano-l-lysine

A concise synthesis of both E-isomers of 2S-amino-3-(2′-aminomethyl- cyclopropyl)propionic acid, new methano-l-lysines, is described. The synthetic route includes nine steps from l-methionine, with a key step involving the cyclopropanation of an intermediate E-allylic alcohol. The resultant hydroxymethylcyclopropanes were readily separated and converted into the title α-amino acids. The stereochemistry around the cyclopropane rings was deduced by conducting the cyclopropanation in the presence of N,N,N′,N′-tetramethyl-d-tartaric acid diamide butylboronate, a chiral controller which is known to favour the production of S-hydroxymethyl cyclopropanes from allylic alcohols.